Absci Company
Absci is the drug & target discovery company harnessing deep learning AI & synthetic biology to expand the therapeutic potential of proteins
Investors
Total Funding:
237859989.0
Headquarters:
Vancouver, Washington, United States
Funding Status:
IPO
Employee Number:
101-250
Estimated Revenue:
$10M to $50M
Last Funding Type:
Venture - Series Unknown
Technology:
['BioTech & HealthTech']
Last Funding Date:
2021-03-23
Investors Number:
23.0
Founded Date:
2011-01-01
Industry:
Medical BioTech